1. Home
  2. GNPX vs AGMH Comparison

GNPX vs AGMH Comparison

Compare GNPX & AGMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genprex Inc.

GNPX

Genprex Inc.

HOLD

Current Price

$2.00

Market Cap

4.2M

Sector

Health Care

ML Signal

HOLD

Logo AGM Group Holdings Inc.

AGMH

AGM Group Holdings Inc.

HOLD

Current Price

$2.16

Market Cap

4.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNPX
AGMH
Founded
2009
2015
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
4.2M
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
GNPX
AGMH
Price
$2.00
$2.16
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
311.5K
36.6K
Earning Date
11-14-2025
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
16.43
Revenue
N/A
$48,526,743.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$0.10
Revenue Growth
N/A
18.80
52 Week Low
$1.71
$1.09
52 Week High
$55.00
$75.00

Technical Indicators

Market Signals
Indicator
GNPX
AGMH
Relative Strength Index (RSI) 38.75 38.21
Support Level $1.71 $1.92
Resistance Level $1.88 $2.50
Average True Range (ATR) 0.17 0.19
MACD 0.05 0.04
Stochastic Oscillator 39.53 33.68

Price Performance

Historical Comparison
GNPX
AGMH

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

About AGMH AGM Group Holdings Inc.

AGM Group Holdings Inc is an integrated technology company. The company focuses on blockchain-oriented ASIC chip design, high-end crypto miner production, and fintech technology software services. The company generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.

Share on Social Networks: